Concepedia

Fangwen Zou

FZ

Statistics

Publications

13

Citations

492

H-Index

13

Active since

2015

Affiliations

Central South University(Current)

Second Xiangya Hospital of Central South University

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

Seattle Cancer Care Alliance

Fangwen Zou is an author at Central South University specializing in oncology, medicine, and molecular oncology.

Publications per year

2015–2024

13

Publications

13

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Fangwen Zou, David M. Faleck, Anusha Shirwaikar Thomas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 117 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Fangwen Zou, Xuemei Wang, Isabella C. Glitza Oliva et al. · Journal for ImmunoTherapy of Cancer · 2021 · 71 citations · Full text

Medicine, Immunology, Oncology +16

Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis

Fangwen Zou, Yifang Tang, Chaoyuan Liu et al. · Frontiers in Genetics · 2020 · 59 citations · Full text

Medicine, Biomedical Informatics, Oncology +12

circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)

Yifang Tang, Zheng-hua Liu, Lei-yi Zhang et al. · Molecular Cancer · 2024 · 41 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer

Jake Jacob, Barbara E. Dutra, Victor Garcia‐Rodriguez et al. · Journal of the National Comprehensive Cancer Network · 2021 · 33 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 13